Abstract
The measurement of renal function or the glomerular filtration rate (GFR) in diabetes can be used 1) to estimate the renal clearance of drugs to guide dosing or to identify patients at increased risk for radiocontrast-induced acute renal failure, 2) for confirming the need for treatment of end stage renal disease, or 3) to measure progression of chronic renal disease i.e. diabetic nephropathy. The evaluation of progression in renal disease is important in the clinical setting for the monitoring of development of renal insufficiency and evaluation of the effectiveness of treatment in the individual, as well as in research to evaluate the importance of putative progression promoters in observational studies or to assess and compare the rate of progression in experimental groups in clinical trials. In order to obtain a valid assessment of the rate of decline in GFR it is necessary with regular measurements of GFR over a period of at least (2)-3 years applying a method with high precision and accuracy [1]. This is due to the usually rather slow rate of decline in GFR in diabetic nephropathy. The ideal method for assessing GFR does not exist and the available methods differ regarding precision and accuracy, cost, inconvenience and safety. In general the more precise methods are being more expensive and inconvenient. Thus one has to select a method according to the clinical situation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Modification of Diet in Renal Disease Study group., Levey AS, Gassman J, Hall PM, Walker WG: Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. J Am Soc Nephrol 1991;1:1087–1094.
Mitch WE, Walser M, Buffington GA, Lemann J: A simple method of estimating progression of chronic renal failure. Lancet 1976;ii: 1326–1328.
Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Ann Rev Med 1988;39:465–490.
Shemesh O, Golbetz HV, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28:830–838.
Jacobsen FK, Christensen CK, Mogensen CE, Andreasen F, Hejlskov NSC: Pronounced increase in serum creatinine concentration after eating cooked meat Br Med J 1979;1:1049–1050.
van Acker BAC, Koome GCM, Koopman MG, de Waart DR, Arisz L: Creatinine clearance during Cimetidine administration for measurement of glomerular filtration rate. Lancet 1992;340:1326–1329.
Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41.
Sampson MJ, Drury PL: Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine. Diabetes Care 1992;15:609–612.
Waz WR, Qattrin T, Feld LG: Serum creatinine, height, and weight do not predict glomerular filtration rate in children with IDDM. Diabetes Care 1993;16:1067–1070.
Rossing P, Astrup A-S, Smidt UM, Parving H-H: Monitoring kidney function in diabetic nephropathy. Diabetologia 1994;37:708–712.
Lewis E, Hunsicker L, Bain R, Rhode R: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993,329:1456–1462.
Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, For The Modification Of Diet In Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877–884.
Levey AS, Bosch JP, Coggins CH, Greene T, Mitch WE, Schluchter MD, Schwab SJ, The Modification of Diet in Renal Disease Study: Effects of diet and blood pressure on creatinine clearance (Co) and serum creatinine (Pcr) in the MDRD study. J Am Soc Nephrol 1993;4:253(Abstract)
Parving H-H, Andersen AR, Smidt UM: Monitoring progression of diabetic nephropathy. Upsala J Med Sci 1985;90:15–23.
Viberti GC, Bilous RW, Mackintosh D, Keen H: Monitoring glomerular function in diabetic nephropathy. Am J Med 1983;74:256–264.
Kasiske BL, Keane WF: Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy; in Brenner BM (ed): The kidney. Philadelphia, Saunders, 1997, pp 1137–1174.
Levey AS: Assessing the effectiveness of therapy to prevent the progression of renal disease. Am J Kidney Dis 1993;22:207–214.
Frimondt-Møller C: Diabetic cystopathy. Dan Med Bull 1978;25:49–60.
Bröchner-Mortensen J: Current status on assessment and measurement of glomerular filtration rate. Clin Physiol 1985;5:1–17.
Bröchner-Mortensen J: Routine methods and their reliability for assessment of glomerular filtration rate in adults with special reference to total [51Cr]EDTA plasma clearance. Dan Med Bull 1978;25:181–202.
Bröchner-Mortensen J, Rödbro P: Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976;36:35–45.
Bröchner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972;30:271–274.
Sambataro M, Thomaseth K, Pacini G, Robaudo C, Carraro A, Bruseghin M, Brocco E, Abaterusso C, DeFerrari G, Fioretto P, Maioli M, Tonolo G, Crepaldi G, Nosadini R: Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans. J Am Soc Nephrol 1996;7:118–127.
Parving H-H, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen FS, Gall M-A: Effective Antihypertensive Treatment Postpones Renal Insufficiency in Diabetic Nephropathy. Am J Kidney Dis 1993;22:188–195.
Chantier C, Garnett ES, Parsons V, Veall N: Glomerular filtration rate measurement in man by the single injection method using 51Cr-EDTA Clin Sci 1969;37:169–180.
Carlsen, J.E., Lehd Moller M, Lund JO, Trap-Jensen J: Comparison of four commercial Tc-99 (sn) DTPA preparations used for the measurement of glomerular filtration rate: concise communication. JNucl Med 1980;126–129.
Rodby RA, Ali A, Rohde RD, Lewis E: Renal scanning 99mTc diethylene-triamine pentaacetic acid glomerular filtration rate (GFR) determination compared with iothalamate clearance GFR in diabetics. Am J Kidney Dis 1992;20:569–573.
Stake G, Monn E, Rootwell IT, Monclair T: The clearance of iohexol as a measure of glomerular filtration rate in children with chronic renal failure. Scand J Clin Lab Invest 1991;51:729–734.
Mantini G, Datton RN, Tomlinson PA The estimation of glomerular filtration rate from single injection plasma inulin measurements using numerical analysis. Abst Paeditr 1989;cl28 (Abstract).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Rossing, P. (1998). Serum Creatinine and other Measures of GFR in Diabetes. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6752-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6752-0_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6754-4
Online ISBN: 978-1-4757-6752-0
eBook Packages: Springer Book Archive